EXHIBIT 8.1
Principal Subsidiaries
Percentage of voting | ||||
At 31 December 2003 | Country | share capital held | Principal activity | |
UK | ||||
AstraZeneca UK Limited | England | 100 | # | Research and development, |
production, marketing | ||||
AstraZeneca Insurance Company Limited | England | 100 | Insurance and reinsurance | |
underwriting | ||||
AstraZeneca Treasury Limited | England | 100 | Treasury | |
Continental Europe | ||||
NV AstraZeneca SA | Belgium | 100 | Marketing | |
AstraZeneca Dunkerque Production SCS | France | 100 | Production | |
AstraZeneca SA | France | 100 | Research, production, marketing | |
AstraZeneca GmbH | Germany | 100 | Development, production, marketing | |
AstraZeneca Holding GmbH | Germany | 100 | Production, marketing | |
AstraZeneca SpA | Italy | 100 | Production, marketing | |
AstraZeneca Farmaceutica Spain SA | Spain | 100 | Production, marketing | |
AstraZeneca AB | Sweden | 100 | Research and development, | |
production, marketing | ||||
AstraZeneca BV | The Netherlands | 100 | Marketing | |
The Americas | ||||
AstraZeneca Canada Inc. | Canada | 100 | Research, production, marketing | |
IPR Pharmaceuticals Inc. | Puerto Rico | 100 | Development, production, marketing | |
AstraZeneca LP | US | 99 | Research and development, | |
production, marketing | ||||
AstraZeneca Pharmaceuticals LP | US | 100 | Research and development, | |
production, marketing | ||||
Zeneca Holdings Inc. | US | 100 | Production, marketing | |
Asia, Africa & Australasia | ||||
AstraZeneca Pty Limited | Australia | 100 | Development, production, marketing | |
AstraZeneca KK | Japan | 80 | Production, marketing | |